Cargando…
A porcine islet-encapsulation device that enables long-term discordant xenotransplantation in immunocompetent diabetic mice
Islet transplantation is an effective treatment for type 1 diabetes (T1D). However, a shortage of donors and the need for immunosuppressants are major issues. The ideal solution is to develop a source of insulin-secreting cells and an immunoprotective method. No bioartificial pancreas (BAP) devices...
Autores principales: | Ajima, Kumiko, Tsuda, Naoto, Takaki, Tadashi, Furusako, Shoji, Matsumoto, Shigeki, Shinohara, Koya, Yamashita, Yzumi, Amano, Sayaka, Oyama, Chinatsu, Shimoda, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939365/ https://www.ncbi.nlm.nih.gov/pubmed/36814843 http://dx.doi.org/10.1016/j.crmeth.2022.100370 |
Ejemplares similares
-
Graft failure after allogeneic islet transplantation in a patient with type 1 diabetes and a high anti‐glutamic acid decarboxylase antibody titer
por: Kodani, Noriko, et al.
Publicado: (2023) -
Quality of life after total pancreatectomy with islet autotransplantation for chronic pancreatitis in Japan
por: Takaki, Tadashi, et al.
Publicado: (2023) -
Exosome loaded immunomodulatory biomaterials alleviate local immune response in immunocompetent diabetic mice post islet xenotransplantation
por: Mohammadi, M. Rezaa, et al.
Publicado: (2021) -
Clinical Islet Xenotransplantation: How Close Are We?
por: van der Windt, Dirk J., et al.
Publicado: (2012) -
Clinical Islet Xenotransplantation: A Step Forward
por: Ekser, Burcin, et al.
Publicado: (2016)